Why we get diarrhea

June 14, 2017, Brigham and Women's Hospital
In the absence of claudin-2, clearance of C. rodentium (red) is impaired and bacteria are able to invade the normally-protected colonic crypt lumen. F-actin (green) and DNA (blue). Credit: Turner laboratory at Brigham and Women's Hospital.

Researchers want to know: does diarrhea serve a purpose? Does it actually help clear the bacteria causing a gastrointestinal infection, or is it merely a symptom of disease that should be prevented as much as possible? In a new study from Brigham and Women's Hospital, investigators explore the immune mechanism that drives diarrhea, concluding that it does play a critical role in pathogen clearance in the early stages of infection. The new study, published today in Cell Host and Microbe, also uncovers a previously unrecognized role for interleukin-22, an immune system molecule, in the host's defense against infection.

"The hypothesis that diarrhea clears intestinal pathogens has been debated for centuries," said corresponding author Jerrold Turner, MD, PhD, of the BWH Departments of Pathology and Medicine. "Its impact on the progression of remains poorly understood. We sought to define the role of diarrhea and to see if preventing it might actually delay pathogen clearance and prolong disease."

To investigate, researchers used a mouse model infected with Citrobacter rodentium, the mouse equivalent of an E. coli . Using this model, they saw an increase in the permeability of the intestinal barrier within just two days of infection—well before inflammation and epithelial damage. In particular, they uncovered a critical role for interleukin-22 that in turn influences another molecule called claudin-2, previously known to be involved in causing diarrhea. They found that diarrhea resulting from the signaling of these two molecules helped promote pathogen clearance and limited disease severity.

Other investigators have proposed developing new therapeutics to inhibit claudin-2. However, Turner and colleagues explain that the activation of this pathway may be critical for combating an infection, particularly in the early stages of a disease. They conclude that is critical to enteric pathogen clearance, and that IL-22 may play a key role in host defense.

Explore further: Microbiologists discover how gut bacterial resources are hijacked to promote intestinal illnesses

More information: Cell Host and Microbe (2017). DOI: 10.1016/j.chom.2017.05.009

Related Stories

Microbiologists discover how gut bacterial resources are hijacked to promote intestinal illnesses

December 10, 2014
UT Southwestern Medical Center microbiologists have identified key bacteria in the gut whose resources are hijacked to spread harmful foodborne E. coli infections and other intestinal illnesses.

Study suggests how flu-related gastrointestinal flare-ups can be relieved while body continues to battle virus the lung

November 3, 2014
Flu infection has long-ranging effects beyond the lung that can wreak havoc in the gut and cause a dreaded symptom, diarrhea, according to a study published in The Journal of Experimental Medicine.

Researchers identify a potential new therapeutic target for E. coli infections

March 28, 2013
(Medical Xpress)—A new study by researchers at the Center for Modeling Immunity to Enteric Pathogens at Virginia Bioinformatics Institute provides novel insight into how an emerging strain of the diarrhea-causing bacteria ...

Controlling levels of specific gut bacteria could help prevent severe diarrhea

November 10, 2015
Everyone has suffered from it. It's ranged from mild to severe. It's a condition that's most-often described in a whisper.

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.